The Pan American Health Organization participated in a workshop convened by Brazil’s Ministry of Health to strengthen health technology transfer processes and support the country’s capacity to expand access to strategic medicines and health products.
The meeting brought together technical contributions from PAHO, the Regionalized Vaccine Manufacturing Collaborative, and experts from key national and regional institutions. Discussions focused on improving methodologies for monitoring and evaluating health technology transfer processes, along with tools to strengthen cost estimation, resource efficiency, and overall outcomes.
Brazil promotes health technology transfer through the Partnerships for Productive Development program, which aims to expand access to medicines and health products considered strategic for the Unified Health System. The initiative also supports the development of Brazil’s Economic-Industrial Health Complex by encouraging innovation, production, and stronger local manufacturing capacity.
Participants included representatives from Brazil’s Ministry of Health, the Pharmaceutical Laboratory of the State of Pernambuco, the Butantan Institute, the Brazilian Association of Official Pharmaceutical Laboratories, the Regionalized Vaccine Manufacturing Collaborative, the National Bank for Economic and Social Development, and PAHO.
As a result of the workshop, participants analyzed methodological criteria and their application in practical cases, exchanged technical recommendations, and agreed to continue collaboration with the Ministry of Health. The cooperation will focus on strengthening methodological frameworks for the design and monitoring of Partnerships for Productive Development and other tools that promote health innovation and production.
The meeting also proposed validating the developed model by involving additional Brazilian producers and regional stakeholders with experience in health technology transfer. This approach is expected to promote greater integration across the production cycle and support more effective implementation of initiatives that expand access to essential health technologies.
